ALGN· Health Care› Medical Instruments & Supplies

Align Technology, Inc.

Stage 4 · Declining · week 7

As of Oct 22, 2026, Align Technology is in Stage 4, the downtrend phase, now in week 7 (since Sep 9, 2026). It closed at $155.51, 21.3% below its 52-week high and below its 200-day average, which is falling.

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. More about the company

$155.51

+2.73% today

$11.0B · Large cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ALGN early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 16w

S4 15w

S4 16w

S2 14w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 6w → S3 4w → S4 11w → S1 10w → S2 7w → S3 7w → S4 16w → S1 2w → S4 13w → S1 2w → S4 15w → S1 10w → S4 16w → S1 9w → S2 14w → S3 11w → S2 4w → S3 1w → S4 6w current

Total tracked: 166 weeks across 19 stage runs.

ALGN among Medical Instruments & Supplies13th of 51 by relative strength

All 51 →

Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	PLSEPulse Biosciences, Inc	Stage 2 · wk 34	98	+1.3%
2	PDEXPro-Dex, Inc.	Stage 2 · wk 36	97	−13.3%
3	HBIOHarvard Bioscience, Inc.	Stage 2 · wk 11	95	+3.6%
4	ATRCAtriCure, Inc.	Stage 2 · wk 10	89	−1.1%
5	WSTWest Pharmaceutical Services, Inc.	Stage 2 · wk 24	82	+4.8%
6	BDXBecton, Dickinson and Company	Stage 2 · wk 11	81	+9.8%
7	ICUIICU Medical, Inc.	Stage 3 · wk 1	81	+3.1%
8	OSUROraSure Technologies, Inc.	Stage 3 · wk 8	75	−4.8%
…13	ALGNAlign Technology, Inc.	Stage 4 · wk 7	65	+5.0%

vs 52W High

-21.3%

$131.91 lo$197.51 hi

21.3% below 52W high, ongoing decline

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 7

1w13w26w

Week 7, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-8.2%

200 DMA: $169.34 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.29x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+5.0%

-6.9%

-18.4%

YTD

-0.3%

+14.2%

Scan Membership

Breakout Watch

Latest: 2024-03-22

8 appearances in last 60 days. First seen: 2019-05-13.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 7 · Vol 1.29x

2026-10-21S4

Wk 7 · Vol 0.79x

2026-10-20S4

Wk 6 · Vol 1.03x

2026-10-19S4

Wk 6 · Vol 0.87x

2026-10-16S4

Wk 6 · Vol 1.08x

2026-10-15S4

Wk 6 · Vol 1.29x

2026-10-14S4

Wk 6 · Vol 0.81x

2026-10-13S4

Wk 5 · Vol 1.12x

2026-10-12S4

Wk 5 · Vol 0.94x

2026-10-09S4

Wk 5 · Vol 1.18x

2026-10-08S4

Wk 5 · Vol 1.46x

2026-10-07S4

Wk 5 · Vol 0.73x

Moving averages & range

50 DMA

$152.51

200 DMA

$169.34

52W High

$197.51

52W Low

$131.91

5D Low

$147.31

Resistance levels (recent highs)

20d High

$155.51

60d High

$181.31

120d High

$188.39

250d High

$197.51

Next resistance

+16.6%

to 60d High

P/E (TTM)

27.0

Forward 12.5

Earnings Growth (YoY)

-12.1%

Revenue +4.3%

ROE

+10.2%

Profit margin +10.0%

Dividend Yield

0.00%

P/B 2.6

Align Technology: quick answers

What stage is Align Technology in?

As of Oct 22, 2026, Align Technology (ALGN) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 9, 2026 and is in week 7. What the four stages mean

Is Align Technology in an uptrend?

No. Align Technology is in a Stage 4 downtrend. It trades 8.2% below its 200-day average, which is falling.

How far is Align Technology from its 52-week high?

Align Technology closed at $155.51 on Oct 22, 2026, 21.3% below its 52-week high of $197.51. Its 52-week low is $131.91.

How has Align Technology performed over the past year?

As of Oct 22, 2026, Align Technology is up 14.2% over the past year and down 0.3% so far in 2026.

Which sector and industry is Align Technology in?

Align Technology is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.